Selumetinib+AZD8186 showed high antiproliferative and proapoptotic activity in PTEN-wt mCRPC cell lines in vitro and significantly decreased tumor growth in PTEN-wt docetaxel-resistant xenograft mouse models in vivo. The gene discussed is PTEN; the disease is neoplasm.